青少年人乳头瘤病毒疫苗系列完成的相关因素
本研究评估美国东南部2017年启动接种的青少年队列在2018年1月至2019年2月期间的HPV疫苗系列完成情况。结果显示64.4%完成系列,53.8%及时完成;启动年龄较小、中等就诊距离和低剥夺社区与较高完成率相关,西班牙裔、非西班牙裔黑人和无私人保险者完成率较低。
要点
- 青少年HPV疫苗系列完成率为64.4%,及时完成率为53.8%。
- 启动接种年龄较小、中等就诊距离和低剥夺社区与较高完成率相关。
- 西班牙裔、非西班牙裔黑人和无私人保险者完成率较低。
核心结论
- 个体和社区层面因素持续影响青少年HPV疫苗系列完成,尽管疫苗剂次已减少。
研究设计与样本
- 研究评估了2017年启动接种的青少年队列在2018年1月至2019年2月期间的系列完成情况,使用多变量逻辑回归分析影响因素。
主要发现
- 64.4%的样本完成了疫苗系列,53.8%及时完成(如14个月内)。
- 启动接种年龄较小者系列完成 odds 较高(AOR=1.94, 95% CI=1.50, 2.50)。
- 中等就诊距离者系列完成 odds 较高(AOR=1.62, 95% CI=1.03, 2.56)。
- 低剥夺社区居民系列完成 odds 较高(AOR=1.85, 95% CI=1.31, 2.60)。
- 西班牙裔(AOR=0.62, 95% CI=0.45, 0.87)、非西班牙裔黑人(AOR=0.66, 95% CI=0.54, 0.81)和无私人保险者(AOR=0.68, 95% CI=0.56, 0.83)系列完成 odds 较低。
临床怎么用
- 针对西班牙裔、非西班牙裔黑人和无私人保险青少年,应加强HPV疫苗系列完成干预。
- 关注启动接种年龄、就诊距离和社区剥夺程度,以改善系列完成率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Most cancers associated with the human papillomavirus are preventable through vaccination. However, adolescent series completion rates are at 75.8%. Two vaccine doses are recommended for adolescents, but factors influencing 2-dose series completion are not well explored. The purpose of this study is to examine individual-level and community-level factors associated with timely human papillomavirus vaccine series completion among adolescents in the Southeastern U.S. METHODS: Series completion was assessed from January 2018 to February 2019 among a cohort of adolescents initiating vaccination in 2017. Factors influencing overall series completion and timely series completion were assessed using multivariable logistic regression. RESULTS: Among the sample, 64.4% completed the vaccine series and 53.8% completed it timely (e.g., 14 months). Higher odds of series completion were among adolescents who were younger at vaccine initiation (AOR=1.94, 95% CI=1.50, 2.50), who traveled moderate distances to the clinic (AOR=1.62, 95% CI=1.03, 2.56), and who lived in low-deprivation neighborhoods (AOR=1.85, 95% CI=1.31, 2.60), and lower among Hispanic (AOR=0.62, 95% CI=0.45, 0.87) and non-Hispanic Black (AOR=0.66, 95% CI=0.54, 0.81) adolescents and among those without private insurance (AOR=0.68, 95% CI=0.56, 0.83). Timely series completion resulted in similar findings; however, lower odds were among Hispanic (AOR=0.63, 95% CI=0.43, 0.95) and non-Hispanic Black (AOR=0.68, 95% CI=0.50, 0.92) adolescents than among non-Hispanic other adolescents. CONCLUSIONS: Individual-level and community-level factors continue to influence adolescent series completion, despite a reduction in doses. Future research is needed to understand racial/ethnic and regional disparities in human papillomavirus vaccine series completion and to develop interventions to promote series completion.
引用
- Mansfield LN, Silva SG, Merwin EI, et al. Factors Associated With Human Papillomavirus Vaccine Series Completion Among Adolescents. Am J Prev Med. 2021. PMID: 34256974. doi:10.1016/j.amepre.2021.04.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。